This website use cookies and similar technologies to improve the site and to provide customised content and advertising. By using this site, you agree to this use. To learn more, including how to change your cookie settings, please view our Cookie Policy
Pocketmags Digital Magazines
Pocketmags Digital Magazines

A new dawn for Sun Kil Moon


MARK KOZELEK (below) the American singer-songwriter who produces albums of dreamy, dolorous folk-rock under the name Sun Kil Moon, gives music journalists heartburn. They post anguished, hand-wringing articles with titles like “The Mark Kozelek Problem,” “My Favorite Singer Is a Jerk” and “Mark Kozelek and Feminist Guilt: Why I Won’t Boycott Sun Kil Moon.” Their problem is reconciling Kozelek’s sometimes loutish behavior—trolling rival band the War on Drugs as “beer-commercial lead-guitar shit,” or telling audience members, “All you fucking hillbillies, shut the fuck up”—with the beauty of his music.

Purchase options below
Find the complete article and many more in this issue of Newsweek International - 24 February 2017
If you own the issue, Login to read the full article now.
Single Issue - 24 February 2017
Or 499 points
Annual Digital Subscription
Only $ 0.67 per issue
Or 3399 points
Monthly Digital Subscription
Only $ 0.94 per issue
Or 399 points

View Issues

About Newsweek International

THE WAR ON ALZHEIMER'S This aggressive attempt to prevent Alzheimer’s rather than treating it is the most exciting new development in decades, as well as a radical departure for researchers and the pharmaceutical industry. Traditionally, drug companies have tested their therapies on patients who already have memory loss, trouble thinking and other signs of dementia. It’s been a losing tactic: More than ninety nine percent of all Alzheimer’s drugs have failed tests in the clinic, and the few that have made it to the market only ameliorate some symptoms. No single medicine has been shown to slow the relentless progression of the disease. However this new approach, even partial success an appreciable slowing of brain degeneration could have a big impact, says Dr. Reisa Sperling, a neurologist who directs the Center for Alzheimer’s Researc.